Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABAZITAXEL for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 764 adverse event reports in the FDA FAERS database where CABAZITAXEL was used for Prostate cancer.

Most Reported Side Effects for CABAZITAXEL

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 197 7.7% 66 119
Malignant neoplasm progression 172 6.7% 18 23
Fatigue 160 6.3% 17 67
Prostatic specific antigen increased 148 5.8% 11 23
Pyrexia 145 5.7% 48 94
Disease progression 143 5.6% 46 27
Diarrhoea 142 5.6% 34 70
Anaemia 127 5.0% 30 58
Neutropenia 126 4.9% 27 50
Drug ineffective 125 4.9% 25 20
Dyspnoea 113 4.4% 42 49
Haematuria 108 4.2% 11 49
Asthenia 101 4.0% 18 59
Decreased appetite 89 3.5% 18 52
Nausea 81 3.2% 13 41

Other Indications for CABAZITAXEL

Hormone-refractory prostate cancer (524) Prostate cancer metastatic (451) Product used for unknown indication (237) Metastases to bone (28) Adenocarcinoma (27) Bladder cancer (23) Neoplasm malignant (20) Chemotherapy (17) Prostate cancer stage iv (15) Bone cancer (11)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

CABAZITAXEL Full Profile All Prostate cancer Drugs CABAZITAXEL Demographics CABAZITAXEL Timeline